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Dose-Response Study of Chloroform
Carcinogenesis in the Mouse and
Rat: Status Report
by Theodore A. Jorgenson,* Carol J. Rushbrook*
and David C. L. Jones*
Chloroform is being administered to male Osborne-Mendel rats and to female B6C3F1 mice at
concentrations of0 (negative control), 200, 400, 900 or 1800 ppm in the drinking water. Matched
control groups of both species receive a volume of water identical to that consumed by the
corresponding 1800 ppm groups. At this writing, the animals have completed 23 months on test.
Negative control and CHCl3-treated rat groups have shown typical growth curves, with
dose-related relative decrements in body weight evident throughout the study. Following
decreases in CHCl3 groups duringthe first 8weeks, rat waterconsumption values have continued
to increase slowly, but persistent relative dose-related decrements are evident. No initial
treatment-related decrements are evident. No initial treatment-related mortality was seen in the
rats. Survival is 21, 41, 45, 76, 70 and 64% for the negative control, 200, 400, 900, 1800 ppm and
matched control groups, respectively. Survival values for mice at three weeks were 99, 94, 74 and
76% for the 200, 400, 900 and 1800 ppm groups, respectively. Mortality was apparently related to
markedly decreased fluid consumption among some of the treated mice. Subsequent mortality
has been less than 15% for all mouse groups. Except for acclimation effects during the first 2-3
weeks, body weights for the treated mouse groups have been generally within 10%o of negative
control values. Tissue changes indecedents have been similar in treated and control groups, both
in rats and mice. Terminal sacrifice and histologic evaluations will be initiated after completion
of 24 months on test.
Introduction
There have been several studies oftumorigenesis
induced in animals by chloroform. Eschenbrenner
(1) reported hepatomas induced in female Strain A
mice receiving 0.3 or 0.6 mg/kg of chloroform by
gavage every four days for three months. In a
study conducted by Hazleton Laboratories in 1976
for the National Cancer Institute (2), chloroform
was administered by gavage five times perweekfor
78weekstoOsborne-Mendelratsat90-250mg/kg/day
and to B6C3F1 mice at 100-500 mg/kg/day. Kidney
epithelial tumors were in("-ed in male rats and
hepatocellular carcinomas in mice of both sexes.
Decreased survival rates and body weights were
reported in treated rats but were not observed in
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the mice. Theiss et al. (3) reported no increase in
lung adenomas in Strain A mice receiving intra-
peritoneal injections of chloroform at 80 or 200
mg/kg three times per week for 8 weeks, or two
injections at 400 mg/kg.
The present study was designed to evaluate the
chronic toxicity and tumorigenicity of chloroform
administeredinthedrinkingwatertomaleOsborne-
Mendel rats and to female B6C3F1 mice over a
wide range of dose levels.
Methods
Animals
The species and strains of rodents used were
those in the earlier study conducted by Hazleton.
Rats were received from CAMM Research, and
mice from Charles River. Mice were housed five142
per cagein48.3 x 26.7 x 15.2 cm(19 x 10.5 x 6in.)
polyearbonate cages containing hardwood chip bed-
ding(AbSorbDri). Cages were changed once aweek
at the same time as the body weights and water
consumption were recorded.
Rats were housed two per cage in 43.2 x 21.6 x
20.3 cm (17 x 8.5 x 8 in.) polyearbonate cages
containing the same hardwood chip bedding. Cages
were changed twice aweek: oncewhenbodyweights
and water consumption were recorded and again
when water consumption was recorded for the sec-
ond time in the week and the cages and racks were
rotated.
Animals were assigned to experimental groups
and cages using a table ofrandom numbers.
For both species cages were rotated on the racks
once a week. The racks were rotated on the same
schedule within the room to ensure similar condi-
tions for all animals throughout the study.
Control animals were housed in rooms as similar
as possible but separate fromthechloroform-treated
groups.
Chemical Supply
The chloroform used in this program was pesti-
cide quality purchased from Matheson Coleman
Bell. The chloroform was analyzed for purity, con-
centrationandstabilityinthedrinkingwater. Before
use, all chloroform was distilled to remove contam-
inants (diethyl carbonate, ethanol, and phosgene).
Distilled water was used throughout the study for
control drinking water as well as for the chloroform
solutions.
Analytical Chemistry
Quantitative analyses forchloroforminair, water,
feed and blood; distillation ofchloroform and deter-
mination of impurity levels; determination of liver
fat/organ weight ratios; and routine monitoring of
feed lots for PCBs and chlorinated pesticides were
performed. Ambient air in each experimental room
was analyzed once every 6 months for chloroform
concentrations. The Purina Laboratory Chow was
analyzed annuallyforchloroformconcentrationwith
each shipment being analyzed for PCBs and chlori-
nated pesticides. Chloroform in blood from addi-
tional rats placed on test for this purpose was
analyzed at 3, 6, 12, and 18 months and will be
evaluated at 24 months on study. Once each month
the stock solutions prepared on Tuesday were ana-
lyzed for chloroform. Additionally, samples from
water bottles were analyzed once each month on
the Friday following the stock solution analysis.
Liver fat/liver weight ratios were examined at 3
and 6 months in both rats and mice.
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Dose Levels and Number ofAnimals
The negative control (0 ppm) and 200 ppm rat
groups were each composed of 330 animals. There
were 150 rats in the 400 ppm group and 50 in the
900ppm, 1800ppmandmatched control(M)groups.
The negative control and 200 ppm mouse groups
each had 430 animals, while the numbers ofmice in
the other groups were identical to the correspond-
ing rat groups.
In addition to the above numbers of animals,
there were 80 additional male rats per group for
blood work and 10 additionalmale rats in allbut the
matched control group for liver fat analyses at 90
days on test. With the exception of the matched
control group, each of the mouse groups had 20
additional mice. Ten mice per group were removed
at 3 months and at 6 months for liver fat analyses.
Observations
Food intake and animal health and activity were
noted daily, 7 days a week. Body weights were
recorded weekly until stable (18 weeks for the rats
and 14weeksforthemice). Thereafter, bodyweight
measurements were recorded monthly. Water con-
sumption was measured twice weekly by weighing
the water bottles during the two changes in water
each week.
Hematology and Blood Chemistry
Blood parameters listed in Table 1 were evalu-
ated on 20 male rats from each experimental group
at 6, 12, and 18 months, and will be evaluated at 24
months on test.
A Coulter Counter Model S was used to deter-
mine red and white cell counts, hemoglobin, hema-
tocrit, MCV, MCH, and MCHC. Differential counts
were conducted manually. The chemical analyses
were run on a Sequential Multiple Analysis Plus
Computer (SMAC) system.
These additional animals were handled in the
same manner as those in the lifetime study. At the
time ofsacrifice for blood analyses, we performed a
gross necropsy and collected and saved the appro-
priate tissues in 10% neutral buffered formalin.
Gross and Microscopic Pathology
Whenanyanimalintheselifetimestudiesappeared
unlikely to survive until the next scheduled obser-
vation, it was sacrificed. This aggressive sacrifice
was intended to prevent the loss ofinformation that
could occur through autolysis or cannibalization.
All decedents were given a complete gross nec-CHLOROFORM CARCINOGENESIS
Table 1. Blood parameters evaluated.
Hematology
Hematocrit
Hemoglobin
Red cell count
White cell count
Differential count
MCV
MCH
Triglycerides
Total bilirubin
SGOT
SGPT
LDH
Alkaline phosphatase
Total iron
Total protein
Albumin
Globulin
A/G ratio
MCHC
Clinical chemistry
Glucose
BUN
Creatinine
Uric acid
Na+
K+
CO2
C1-
Calcium
Phosphorus
Balance (Na-(Cl + CO2))
Cholesterol
Table 2. Measured chloroform concentrations in water bottles in percent of nominal values.a
Percentage of nominal values at various chloroform levels
Month 200 ppm 400 ppm 900 ppm 1800 ppm
1 93 94 88 76
2 84 93 95 94
3 104 108 80 94
4 92 84 89 89
5 99 102 100 99
6 106 94 90 73
7 106 100 101 98
8 107 97 96 98
9 103 104 105 103
10 104 104 100 94
11 95 96 91 88
12 89 88 88 83
13 96 98 94 97
14 90 95 92 89
15 100 104 100 97
16 108 100 100 105
17 100 103 121 96
18 91 87 95 94
19 104 102 101 98
20 104 104 101 105
21 104 100 107 96
22 92 93 90 79
23 105 100 110 109
24 117 111 109 99
aMean of ten samples per level per month.
ropsy as defined in the Guidelines for Carcinogen
Bioassay in Small Rodents, DHEW Publication No.
(NIH) 78-23, Revised 1978, including examination
ofexternal surfaces and body orifices, and examina-
tion and fixation ofall ofthe following: gross lesions,
tissue masses or suspect tumors and regional lymph
nodes, skin, mandibular lymph node, mammary
gland, salivarygland, larynx, trachea, cecum, colon,
rectum, mesenteric lymphnode, liver, thighmuscle,
lungs and bronchi, heart, thyroids, parathyroids,
esophagus, stomach, duodenum, jejunum, ileum,
spleen, kidneys, adrenals, bladder, seminalvesicles,
prostate, sciatic nerve, sternebrae or vertebrae, or
femur (plus marrow), costochondral junction, ribs,
thymus, gall bladder, pancreas, testes, ovaries,
uterus, nasal cavity, brain, pituitary, eyes and spi-
nal cord. All tissues and organs were fixed in 10%
neutral buffered formalin.
The following tissues were processed and read
histologically, with allothersbeingstoredinfixative:
suspect tumors and gross lesions, liver, kidney,
regional lymph nodes, urinary bladder, esophagus,
adrenals, spleen, stomach, small intestine, colon
and lung. All rat slides were read by one patholo-
gist, and all mouse slides were read by another
pathologist.
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Results
Since this study is still in progress, the results
presented here are necessarily incomplete. None-
theless, they provide a basis for evaluating the
progress of the study and some information about
the chronic effects of chloroform.
Table 2 shows the results of the analyses of the
chloroform solutions in the drinking bottles. Chlo-
roform concentrations varied- somewhat over the
course of the study, but were generally within ten
percent of the nominal values. Clearly, there were
nooverlapping valuesbetweenadjacent dose groups.
Survival, water consumption, and body weight
patterns for the rats are shown in Figure 1. Sur-
vival has been essentially directly proportional to
the chloroform dose level; lowest for the negative
controls, next lowest for the 200 and 400 ppm
groups, and highest for the matched controls and
the 900 and 1800 ppm groups. Water consumption
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has increased slowly over the course ofthe study in
all groups, with the amount consumed inversely
proportionaltodoselevelduringthefirst 18months,
then a clustering of the negative control, 200 and
400 ppm groups at a relatively higher level, the 900
ppm group in the middle, and the 1800 ppm group
at a lower level. Body weight patterns have shown
typical growth curves, the values at any time point
being inversely proportional to dose level. Values
for the matched control group were above those for
the 1800 ppm group during the first year, but the
latter group has now caught up with its matched
controls.
Survival, water consumption and body weight
patterns for the mice are illustrated in Figure 2.
Unlike the rats, there was significant early mortal-
ity in the treated mice, particularly at 900 and 1800
ppm. Fromthe secondthroughthe eighteenthmonth
very few animals died, but by the twenty-third
month some mortality, proportional to dose level,
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FIGURE 1. Survival, water consumption and body weight in
male Osborne-Mendel rats receiving chloroform in the drink-
ing water. Doses are indicated in ppm; M indicates matched
control group receiving an amount of water equal to that
consumed by the 1800 ppm group.
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FIGURE 2. Survival, water consumption and body weight in
female B6C3F1 mice receiving chloroform in the drinking
water. Doses are indicated in ppm; M indicates matched
control group receiving an amount of water equal to that
consumed by the 1800 ppm group.
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LTable 3. Mean percent liver fat in animals receiving chloroform in the drinking water.
3 Months 6 Months
Dose group N S N %
Rats 0 ppm 10 3.3 20 4.5
M 18 4.6
200 ppm 10 3.3 20 4.5
400 ppm 10 3.2 20 4.6
900 ppm 10 3.6 19 4.8
1800 ppm 10 3.5 19 5.la
Mice 0 ppm 10 3.3 7 5.8
200 ppm 10 3.5 10 7.9a
400 ppm 10 3.9b 10 6.8
900 ppm 10 4.5b 6 7.1a
1800 ppm 8 6.4 8 10.4b
ap < 0.05.
bp > 0.01.
was apparent. Both water consumption and body
weights were narrowly distributed amongthe vari-
ous groups. The values forthe two extreme groups,
the negative controls and the 1800 ppm group, are
shown for illustration. Water consumption for the
mice was essentially stable throughout the study.
Body weight increased more or less linearly, then
reached a plateau beginning at about 18 months.
Although mean blood levels of chloroform were
assessed in the rats at 3, 6, 12 and 18 months, there
was difficulty in obtaining reliable data during the
first year. Forthe 18-month assay, wholeblood was
used instead of serum, and reliable results were
obtained. Values were 0.7, 0.8, 7.5, 22.1, 75.4 and
124 ppb for the negative controls, matched con-
trols, and the 200, 400, 900 and 1800 ppm groups,
respectively.
The percent fat in the liver of the rats and the
mice at 3 and at 6 months is shown in Table 3. For
the rats, there was no apparent increase in liver fat
content in the treated groups at 3 months, but at 6
months there was a significant increase in the 1800
ppm group. In the mice, significant increases in
liverfat were apparent at400-1800 ppm at 3 months
and at 900 and 1800 ppm at 6 months.
The hematologic findings in the rats at 6, 12 and
18 months are shown in Tables 4-6. WBC values
were lower in the 1800 ppm group and in the
matched controls at 6 and at 12 months. The differ-
ences in erythrocyte and hemoglobin parameters at
12 months are consistent with hemoconcentration
in the treated groups, but no significant differences
were apparent at 18 months.
The blood chemistry data for male rats sacrificed
at 6, 12 and 18 months are shown in Tables 7-9.
Although various parameters differed significantly
fromthenegativecontrolvaluesat sometimepoints,
there were a number ofapparent trends. Chloride,
Table 4. Summary of hematology data for male Osborne-Mendel rats receiving chloroform in their drinking water: 6-month
sacrifice.
Chloroform
Parameter Control Matched control 200 ppm 400 ppm 900 ppm 1800 ppm
WBC x 103/MM3 6.8 4.8a 6.6 6.5 6.8 5.5a
RBC x 106/mm3 8.06 8.14 8.19 8.07 8.04 7.98
Hgb, g-% 15.3 15.4 15.5 15.3 15.2 15.3
Hct, % 44.2 44.3 44.4 43.6 43.7 44.0
MCV,I 3 55 55 54 54 55 55.
MCH, >Ig 18.9 18.7 18.8 18.7 18.8 19.0
MCHC, % 34.7 34.7 35.0 35.0 34.9 34.8
Differential
PMN,% 10.7 14 13 12 11 12
Bands, % 0 0.1 0.1 0 0.1 0
Lymphocytes, % 85 82 84 85 86 84
Monocytes, % 2.5 2 2 2 2 2
Eosinophils, % 2 2 1.6 1 1 2
Basophils, % 0 0 0 0 0 0
ap 0.05.
bp 0.01.
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Table 5. Summary of hematology data for male Osborne-Mendel rats receiving chloroform in their drinking water: one-year
sacrifice.
Chloroform
Parameter Control Matched controla 200 ppm 400 ppm 900 ppm 1800 ppm
WBC x 103/mm3 6.7 5.9b 6.6 6.4 5.0b 4.4b
RBC x 106/mm3 7.84 7.98 8.17b 7.97 8.31b 7.97
Hgb, g-% 14.9 15.2 15.3c 15.2 15.6b 15.4c
Hct, % 43.1 44.6c 43.4 44.4 45.lb 44.4C
MCV,I3 55 56 53b 56 55 56
MCH, p.p.g 18.9 18.9 18.7 19.0 18.7 19.2
MCHC, % 34.4 33.9 35.3c 34.0 34.5 34.5
Differential
PMN,% 20 19 16 14 17 16
Bands,% 0 0 0 0 0 0
Lymphocytes, % 78 79 81 84 80 81
Monocytes, % 2 1 1 1 2 1
Eosinophils, % 1 1 1 1 2 2
Basophils, % 0 0 0 0 0 0
aOne sample clotted, therefore, only 19 samples were analyzed for this level. All other levels contained 20 samples. The differential
count for this level contained 20 samples.
p S 0.01.
cp < 0.05.
Table 6. Summary of hematology data for male Osborne-Mendel rats receiving chloroform in their drinking water: 18-month
sacrifice.
Chloroform
Parameter Control Matched controla 200 ppm 400 ppm 900 ppm 1800 ppm
WBC x 103/mm3 6.6 6.2 6.0 6.7 5.8 6.4
RBC x 106/mm3 7.43 7.57 7.38 7.66 7.76 7.49
Hgb, g-% 14.4 14.7 14.4 15.0 14.9 14.4
Hct, % 41.6 42.8 41.4 42.8 42.5 41.5
MCV, ,3 56 57 57 56 55 56
MCH, ,ug±g 19.4 19.4 19.5 19.6 19.2 18.7
MCHC, % 34.8 34.3 34.7 35.2 35.0 34.7
Differential
PMN,% 21 21 19 21 20 27
Bands, % 0 0 0 0 0 0
Lymphocytes, % 74 76 77 75 77 69
Monocytes, % 3 2 2 3 2 2
Eosinophils, % 2 2 2 1 1 2
Basophils, % 0 0 0 0 0 0
aOne sample clotted; therefore, only 19 samples were analyzed for this level. All other levels contained 20 samples. The differential
count for this level contained 20 samples.
potassium, phosphorus, bilirubin, alkaline phospha-
tase, total iron, albumin and the albumin/globulin
ratio tended to be higher in treated groups than in
the negative controls. Cholesterol, triglycerides,
LDH and globulin tended to be lower in treated
groupsthaninthenegativecontrols. Inthematched
controls, glucose and total iron tended to be higher
and cholesterol and triglycerides tended tobe lower
than in the negative controls. In summary, most of
the changes in hematologic and blood chemistry
parameters observed in the treated groups were
also evident in the matched control group. Thus,
these effects of chloroform appear to be secondary
to reduced water and food consumption.
Histopathologic evaluations have been completed
for 200 rats and 62 mice that were sacrificed or
found dead during the first 20 months ofthe study.
From the mortality data, it is apparent that these
samples are highly biased both in time and toward
negative control animals. The percentages of rats
examined to date are 45, 12, 10, 5, 6 and 4% for the
negative control, matched control, 200, 400, 900
and 1800 ppm groups, respectively. Corresponding
percentages for the mice are 3, 4, 4, 6, 20 and 18%
146Table 7. Summary of clinical chemistry data for male Osborne-Mendel rats receiving chloroform in their drinking water:
6-month sacrifice.
Chloroform
Parameter Control Matched control 200 ppm 400 ppm 900 ppm 1800 ppm
Glucose, mg-% 182 215a 180 187 201 193
BUN, mg-% 22 24.4b 21.6 20.6 21.2 26.3b
Creatinine, mg-% 0.6 0.6 0.6 0.6 0.7 0.7a
Uric acid, mg-% 2.0 2.9 2.1 2.1 2.5 2.9
Na+, meql1. 146 147 146 146 146 145
K+, meql1. 5.3 5.9 5.2 5.4 5.6 6.4b
C02, meqf1. 24.0 24.8 26.6 27.0 26.0 26.0
ClV, meqf1. 99.7 96.3 99.7 100 102b 102b
Calcium, mg-% 10.0 10.0 9.9 10.1 10.3b 10.5b
Phosphorus, mg-% 5.9 5.8 6.0 6.1 6.7b 7.4b
Blance, Na-(Cl + C02) 22 20 20 18.5b 18b 18b
Cholesterol, mg-% 111 89a 107 114 103 100
Triglycerides, mg-% 127 69b 120 116 68b 32b
Total bilirubin, mg-% 0.13 0.13 0.13 0.13 0. 7a 1.l7b
SGOT, mU/ml 180 170 135 127 114a 129
SGPT, mU/ml 114 101 81 82 47 91
LDH, mU/ml 1828 1169b 1195b 994b 821b 744b
Alkaline phosphatase, mU/ml 194 221 180a 173 165 197
Total iron, ptg-% 182 193 170 188 209b 202
Total protein, g-% 5.7 5.9 5.6 5.6 5.7 5.7
Albumin (A), g-% 2.8 3.Oa 2.8 2.8 3."b 3.lb
Globulin (G), g-% 2.8 2.9 2.8 2.8 2.7a 2.6b
A/G 1.0 1.05 1.0 1.05 1.lb 1.2
ap 6 0.05.
p 0.01.
Table 8. Summary of clinical chemistry data for male Osborne-Mendel rats receiving chloroform in their drinking water:
one-year sacrifice.
Chloroform
Parameter Control Matched control 200 ppm 400 ppm 900 ppm 1800 ppm
Glucose, mg-% 182 240k 183 220 220 221
BUN, mg-% 22 23 20b 21 21 24b
Creatinine, mg-% 0.7 0.8 0.7 0.8 0.7 0.8
Uric acid, mg-% 2.3 3.1 2.0 3.5 3.5 3.1
Na+, meq/1. 146 149b 146 147 146 146
K+, meq/1. 5.1 6.3a 5.1 6.6b 6.6 7.Oa
C02, meq/1. 27 25 27 25 25 24a
C1, meq/l. 99 103b "olb 99 1olb 103b
Calcium, mg-% 10.6 10.5 10.4 10.8 10.9 10.7
Phosphorus, mg-% 5.4 6. la 5.2 6.3b 6.1k 6.7b
Balance, Na-(Cl + C02) 20 21 18a 22 21 19
Cholesterol, mg-% 159 112b 146 169 127b 105b
Triglycerides, mg-% 323 138b 257 249 glb 34b
Total bilirubin, mg-% 0.1 0.1 0.1 0.1 0.2b 0.2b
SGOT, mU/ml 204 211 136a 221 166 163
SGPT, mU/ml 112 117 100 156 145 105
LDH, mU/ml 1386 1380 1065b 1169 1059a 668b
Alkaline phosphatase, mU/ml 167 i48a 161 140b 174 218b
Total iron, jg-% 164 193b 181a 183a 213b 231b
Total protein, g-% 5.8 5.9 5.9 5.9 6.0 6.0
Albumin (A), g-% 2.6 2.8 2.7 2.4 2.8a 3.Oa
Globuin (G), g-% 3.2 3.1 3.2 3.4b 3.2b 3.0b
A/G 0.8 0.9 0.9 0.7a 0.8 1.0b
ap 6 0.05.
bp 0.0 o1.
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Table 9. Summary of clinical chemistry data for male Osborne-Mendel rats receiving chloroform in their drinking water:
18-month sacrifice.
Chloroform
Parameter Control Matched control 200 ppm 400 ppm 900 ppm 1800 ppm
Glucose, mg-% 185 213 177 169 195 178
BUN, mg-% 32 24 36 26 22a 25
Creatinine, mg-% 0.8 0.7 0.9 0.7a 0 b 0.7
Uric acid, mg-% 1.9 2.9a 2.1 2.0 2.2 2.2
Na+, meq/l. 148 148 148 149 148 148
K+, meq/l. 5.1 6.0 5.3 5.0 5.1 6.2b
C02, meq/l. 29 27 30 30 29 29
Cl, meq/l. 102 102 100a 101 102 104a
Calcium, mg-% 10.3 10.2 10.5 10.2 10.2 10.1
Phosphorus, mg-% 5.2 5.5 5.2 4.9 5.3 6.4b
Balance, Na-(Cl + C02) 17 19 18 18 17 15
Cholesterol, mg-% 233 157b 231 200 157b 121b
Triglycerides, mg-% 375 225 373 255 130b 41b
Total bilirubin, mg-% 0.1 0.1 0.1 0.1 0.1 0.1
SGOT, mU/ml 99 153b 106 99 122 92
SGPT, mU/ml 61 98b 70 68 82 82a
LDH, mU/ml 944 1005 1028 854 778 560
Alkaline phosphatase, mU/ml 122 170b 119 124 135 167b
Total iron, 11g% 119 165b 147a 140a 161b 162b
Total protein, g-% 5.4 5.5 5.5 5.4 5.5 5.4
Albumin (A), g-% 2.2 2.3 2.2 2.2 2.5b 2.6b
Globulin (G), g-% 3.8 3.1 3.3 3.2 3.Oa 2.8b
A/G 0.7 0.7 0.7 0.7 0.8b o.gb
ap G 0.05.
bp 0.01.
(including early deaths). Thus, assessment of the
effect ofchloroform ontumorigenesisis notpossible
at this time.
For the rats, the conditions listed in Table 10
have been observed in appreciable numbers in the
indicated sites.
In addition, sporadic tumor diagnoses have been
made in the rats in various organs, including dis-
seminated lymphosarcoma; adenocarcoma in the GI
tract; squamous cell carcinoma, undifferentiated
sarcoma, and sebaceous gland adenoma in the ear;
Schwannoma in the eye; fibrosarcoma in the heart;
tubular carcinoma, clear cell adenoma, adenocarci-
noma, transitional cell carcinoma, and hemangio-
sarcoma in the kidney; bronchiolar adenoma in the
lung; osteosarcoma; fibroma, sarcoma, fibrosarcoma,
fibroadenoma, andhemangiosarcomainvariousbody
regions; squamous cell carcinoma in the nostril;
carcinoma in the nasal cavity; parathyroid adeno-
ma; basophilic carcinomain the pituitary; adenocar-
cinoma in the prostate; squamous cell carcinoma
and papilloma inthe stomach; interstitial cell tumor
in the testes; and carcinoma, cystadenoma, and
adenoma in the thyroid.
There have been insufficient mice examined to
identify any lesions of appreciable incidence. Spo-
radic tumors in the mice have been diagnosed as
disseminated lymphoma, both histiocytic and lym-
Table 10. Conditions observed.
Site Conditions
Adrenal cortex Adenoma, hyperplasia, hypertrophy,
vacuolation
Adrenal medulla Pheochromocytoma, hyperplasia
Kidney Cyst, calculi, glomerulonephritis,
hydronephrosis
Lung Arterial hypertrophy, atelectasis,
congestion, interstitial pneumonia
Lymph nodes Hemorrhage
Parathyroids Hyperplasia
Spleen Hematopoiesis, hemosiderosis
Stomach Mineralization
phocytic; pheochromocytoma; alveolar/bronchiolar
adenoma and carcinoma; mammary adenoma and
adenocarcinoma; carcinoma and teratoma in the
ovary and leiomyosarcoma in the uterine cervix.
Discussion
With administration of chloroform at constant
levelsinthedrinkingwater, thedailydosesreceived
by the animals are a function of fluid consumption
and body weight. Usingthe water consumption and
body weights for the first and twenty-third months
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for illustration, the calculated mean daily doses for
the rats receiving 200, 400, 900 or 1800 ppm of
chloroform were 34, 66, 143 and 305 mg/kg and 34,
69, 132 and 238 mg/kg, during months 1 and 23,
respectively. For the mice, the corresponding val-
ues were 54, 95, 207 and 382 mg/kg and 31, 63, 150
and 309 mg/kg. Thus, the daily doses in the present
study were comparable to those used in two previ-
ous studies (2,3) at the higher levels and extended
below them at the lower levels.
If it is assumed that the water consumption and
body weight data provide indices of food consump-
tion, the increased survival and decreased body
weight in rats receiving chloroform are consistent
with the well-known increase in longevity associ-
ated with caloric restriction (4). Since caloricrestric-
tion also results in reduced age-specific incidences
ofmost pathologic conditions associated with aging
(4), it will be intresting to consider the pathologic
findings from the present study when they become
available. Itisalsoevidentthatinclusionofmatched
controls in long-term studies is extremely impor-
tant.
In the mice the effect of chloroform on survival
was markedly different than that in the rats. It
appears that some of the mice rejected the chloro-
form solutions during the first weeks to such a
degree that they were unable to survive. In fact,
the only behavioral effect of the chloroform that
was discernible during this study was the unthrifty
appearance (e.g., lack of vigor, lassitude) of the
mice duringthis time. Fromthe waterconsumption
and bodyweight data, it is clear that caloric restric-
tion in the mice surviving the first weeks occurred
to a much lesser extent than in the rats, if at all.
The increase in liver fat content for the mice was
clearly greaterthan forthe rats. It is probablethat,
in addition to differences between the mouse and
the rat in the metabolism of chloroform (5, 6), the
greater caloric restriction in the rats may have
been a factor in reducing the relative accumulation
of fat in the liver.
While the trends observed in some of the blood
chemistry parameters associated with chloroform
administration in the rat may be related to a neph-
rotoxic effect ofthe chloroform, nephropathy is one
of the findings in the negative controls, and no
definitive statements about the nephrotoxic effects
of chloroform in the present study can be made at
this time.
Discussion of the gross necropsy and histologic
information will have be delayed until the terminal
sacrifices and the histopathologic evaluations have
been completed.
This study has been supported by EPA Contract 68-03-2616.
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